Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

LCN may improve finasteride delivery for hair loss treatment.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Activin B improves wound healing and hair growth by helping stem cells move using certain cell signals.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Genetic differences affect COVID-19 severity and treatment development.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.